Unilateral Occipital Transtentorial Approach with Multimodal Assistance for Resection of Large Supracerebellar Hemangioblastomas: Preliminary Experience of 2 Cases.

Journal: World Neurosurgery
Treatment Used: Unilateral Occipital Transtentorial Approach with Multimodal Assistance for Resection
Number of Patients: 2
Published:
MediFind Summary

Summary: This article reported on 2 cases of large supracerebellar hemangioblastomas (SHBs) that were successfully and safely resected via a unilateral occipital transtentorial approach (OTA) with multimodal assistance.

Conclusion: The combination of an occipital transtentorial approach with preoperative embolization and endoscopic assistance may reduce the intraoperative risk and contribute to improved outcome in patients with such clinically challenging tumors as large supracerebellar hemangioblastomas.

Abstract

Background: The surgical resection of large supracerebellar hemangioblastomas (SHBs) is exceptionally challenging due to their vascularity and deep anatomic location and is associated with a high risk of postoperative complications and mortality. Access to the posterior incisural space can be achieved by either an infratentorial supracerebellar approach or occipital transtentorial approach (OTA). However, the optimal surgical strategy has not yet been established. Here, we report 2 cases of large SHBs that were successfully and safely resected via a unilateral OTA with multimodal assistance.

Methods: Two patients presented to our hospital with ataxia due to large, solid SHBs. After preoperative embolization, gross total resection of the SHBs was achieved via an OTA. Furthermore, endoscopic assistance was used to resect the remnant portion of the tumor in the second patient. Both patients experienced transient ataxia but were discharged from the hospital without serious complications.

Conclusions: The combination of an OTA with preoperative embolization and endoscopic assistance may reduce the intraoperative risk and contribute to improved outcome in patients with such clinically challenging tumors.

Similar Latest Advances